Artykuł w czasopiśmie
Brak miniatury
Licencja
ClosedAccessDostęp zamknięty
 

Under-reporting of Corporate R&D Expenditure in Poland - Consequences for Verifying Possible Crowding-out Effect of Private Investment by Public Subsidies : Evidence from Polish Pharmaceutical Sector

Uproszczony widok
dc.affiliationUniwersytet Warszawski
dc.conference.countryRumunia
dc.conference.datefinish2017-06-08
dc.conference.datestart2017-06-07
dc.conference.placeBukareszt
dc.conference.series12th International Conference Accounting and Management Information Systems AMIS 2017
dc.conference.series12th International Conference Accounting and Management Information Systems AMIS 2017
dc.contributor.authorGRABIŃSKA, BARBARA
dc.contributor.authorBiałek-Jaworska, Anna
dc.date.accessioned2024-01-26T11:18:58Z
dc.date.available2024-01-26T11:18:58Z
dc.date.issued2017
dc.description.financeNie dotyczy
dc.description.volumeR. 17
dc.identifier.issn2247-6245
dc.identifier.urihttps://repozytorium.uw.edu.pl//handle/item/124151
dc.identifier.weblinkhttps://amis.ase.ro/2017/docs/AMIS2017Proceedings.pdf
dc.languageeng
dc.pbn.affiliationeconomics and finance
dc.relation.ispartofProceedings of the International Conference "Accounting and Management Information Systems"
dc.relation.pages478-498
dc.rightsClosedAccess
dc.sciencecloudnosend
dc.titleUnder-reporting of Corporate R&D Expenditure in Poland - Consequences for Verifying Possible Crowding-out Effect of Private Investment by Public Subsidies : Evidence from Polish Pharmaceutical Sector
dc.typeJournalArticle
dspace.entity.typePublication